ribavirin has been researched along with Lymphoma, B-Cell in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matutes, E | 2 |
| Alric, L; Besson, C; Bonnet, D; Cacoub, P; Canioni, D; Davi, F; Hermine, O; Jeannel, J; Lapidus, N; Michot, JM; Pol, S; Rabiega, P; Ysebaert, L | 1 |
| Arcaini, L; Carli, G; Merli, M; Visco, C | 1 |
| Brito-Zerón, P; Cacoub, P; Casato, M; Ferri, C; Lamprecht, P; Mangia, A; Ramos-Casals, M; Retamozo, S; Saadoun, D; Tzioufas, AG; Younossi, ZM; Zignego, AL | 1 |
| Asada, M; Fukunaga, T; Ito, H; Kato, Y; Kawaguchi, K; Kou, T; Kudo, Y; Nakamura, T; Oda, Y; Ohashi, S; Sakuma, Y; Sugiura, Y; Taguchi, N; Watanabe, M; Yamauchi, A; Yazumi, S | 1 |
| Pellicelli, AM; Zoli, V | 1 |
| Ignatova, TM; Mukhin, NA | 1 |
| Emens, LA; Sulkowski, MS | 1 |
| Lai, MM; Levine, AM; Shimodaira, S | 1 |
| Barozzi, P; Luppi, M; Morselli, M; Potenza, L; Riva, G; Torelli, G | 1 |
| Blanche, P; Bouscary, D; Calmus, Y; Christoforov, B; Dreyfus, F; Kelaidi, C; Park, S; Podevin, P; Rollot, F; Sogni, P; Tulliez, M | 1 |
| Anselmi, E; Arcaini, L; Arcari, AL; Bernuzzi, P; Bertè, R; Callea, V; Cavanna, L; Lazzarino, M; Lazzaro, A; Marasca, R; Moroni, C; Sacchi, S; Trabacchi, E; Vallisa, D | 1 |
| Mazzaro, C; Spina, M; Tirelli, U | 1 |
| Cacoub, P; Fois, E; Halfon, P; Landau, DA; Marcellin, P; Martinot-Peignoux, M; Saadoun, D | 1 |
| Attias, D; Rowe, JM; Sabo, E; Sahar, D; Streichman, S; Yeshurun, D; Zuckerman, E; Zuckerman, T | 1 |
5 review(s) available for ribavirin and Lymphoma, B-Cell
| Article | Year |
|---|---|
Splenic marginal zone lymphoma: disease features and management.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Clinical Trials as Topic; Humans; Interferon-alpha; Lymphoma, B-Cell; Prognosis; Purines; Receptor, Notch2; Ribavirin; Rituximab; Splenic Neoplasms | 2013 |
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.
Topics: Antiviral Agents; Clinical Trials as Topic; Genotype; Hepatitis C; Humans; Interferons; Lymphoma, B-Cell; Ribavirin; Treatment Outcome | 2016 |
Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection.
Topics: Antiviral Agents; Autoimmune Diseases; Cryoglobulinemia; Evidence-Based Medicine; Hepatitis C, Chronic; Humans; Interferons; Lymphoma, B-Cell; Ribavirin; Rituximab; Vasculitis | 2017 |
[Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell; Ribavirin; Rituximab; Vasculitis | 2012 |
Splenic marginal zone lymphoma with and without villous lymphocytes.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; B-Lymphocytes; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, B-Cell; Recombinant Proteins; Ribavirin; Splenectomy; Splenic Neoplasms | 2007 |
1 trial(s) available for ribavirin and Lymphoma, B-Cell
| Article | Year |
|---|---|
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.
Topics: Adult; Aged; Antiviral Agents; Disease Progression; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, B-Cell; Male; Middle Aged; Polyethylene Glycols; Prognosis; Prospective Studies; Recombinant Proteins; Ribavirin; Viral Load | 2005 |
10 other study(ies) available for ribavirin and Lymphoma, B-Cell
| Article | Year |
|---|---|
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Proportional Hazards Models; Protease Inhibitors; Recombinant Proteins; Ribavirin; RNA, Viral; Survival Rate; Treatment Outcome | 2016 |
Regression of B-cell lymphoma of the liver with hepatitis C virus infection after treatment with pegylated interferon-alpha and ribavirin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Biopsy; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Lymphoma, B-Cell; Magnetic Resonance Imaging; Neoplasm Staging; Radiotherapy, Adjuvant; Ribavirin; Treatment Outcome | 2010 |
Role of ribavirin in hepatitis flare in HCV-infected patients with B cell non Hodgkin's lymphoma treated with rituximab-containing regimens.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Female; Hepatitis C; Humans; Immunologic Factors; Lymphoma, B-Cell; Male; Middle Aged; Recurrence; Ribavirin; Rituximab | 2011 |
Regression of splenic lymphoma after treatment of hepatitis C virus infection.
Topics: Antiviral Agents; Cryoglobulinemia; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Lymphoma, B-Cell; Ribavirin; RNA, Viral; Splenic Neoplasms | 2002 |
Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa.
Topics: Aged; Antiviral Agents; Cell Line, Tumor; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Ribavirin; Splenic Neoplasms; Viral Load | 2003 |
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems?
Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell; Ribavirin; Treatment Outcome | 2004 |
Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell; Male; Middle Aged; Prospective Studies; Retrospective Studies; Ribavirin; Treatment Outcome | 2004 |
Regression of low-grade non-Hodgkin's lymphoma after treatment with pegylated interferon plus ribavirin in hepatitis C virus infection.
Topics: Antiviral Agents; Cryoglobulins; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, B-Cell; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Topics: Adult; Aged; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Lymphoma, B-Cell; Male; Middle Aged; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Vasculitis; Virus Replication | 2008 |
The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection.
Topics: Adult; Aged; Antiviral Agents; B-Lymphocytes; Cell Division; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Drug Therapy, Combination; Female; Gene Rearrangement; Genes, bcl-2; Hepatitis C, Chronic; Humans; Immunoglobulin Heavy Chains; Interferon-alpha; Lymphoma, B-Cell; Male; Middle Aged; Ribavirin; Translocation, Genetic | 2001 |